Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 248Rectal Neoplasms 154Pancreatic Neoplasms 124Stomach Neoplasms 105Colonic Neoplasms 104Esophageal Neoplasms 90Neoplasm Metastasis 69Breast Neoplasms 61Squamous Cell Carcinoma of Head and Neck 47Carcinoma, Hepatocellular 42Adenocarcinoma Of Esophagus 41Head and Neck Neoplasms 39Esophageal Squamous Cell Carcinoma 38Neoplasms 37Nasopharyngeal Carcinoma 30Adenocarcinoma 24Cholangiocarcinoma 19Keratosis, Actinic 17Carcinoma, Squamous Cell 16Biliary Tract Neoplasms 16Liver Neoplasms 15Gastrointestinal Neoplasms 15Anus Neoplasms 14Gallbladder Neoplasms 11Bile Duct Neoplasms 11Peritoneal Neoplasms 10Laryngeal Neoplasms 9Recurrence 8Nasopharyngeal Neoplasms 7Colorectal Cancer Metastatic 7

Interventions

Oxaliplatin 3Irinotecan 3Fluorouracil 3Capecitabine 3Bevacizumab 3Leucovorin 2Colonoscopy 2Bisacodyl 2Aspirin 2lutetium Lu 177 dotatate 1guadecitabine 1copper dotatate CU-64 1camrelizumab 1apatinib 1aldesleukin 1XELOX 1Ursodeoxycholic Acid 1Trastuzumab 1Suction 1Simvastatin 1Radiotherapy 1Polyethylene Glycols 1Oviposition 1Lutetium-177 1Lutetium 1Ileostomy 1Folfox protocol 1Drainage 1Cyclophosphamide 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Intestinal Neoplasms × Fluorouracil × Clear all
NCT02241499 2020-02-28

PALAESTRA

Lund University Hospital

Phase 2 Completed
29 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms

NCT01996306 2019-01-08

AXEPT

Epidemiological and Clinical Research Information Network

Phase 3 Completed
650 enrolled
Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT03303495 2017-10-06

A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

Sun Yat-sen University

Phase 3 Unknown
280 enrolled
Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡